Clinical Trials in Pittsburgh

Showing 3301-3320 of 12,518 trials

Impairments That Affect Correct Inhaler Use in COPD

NCT06135324

INHALE is a one-year, multi-site observational research study funded by Viatris, with two aims: 1. Determine the prevalence of both cognitive impairment and impaired manual dexterity in stable out-patients with chronic obstructive pulmonary disease (COPD). 2. Assess the relationship of cognitive impairment and impaired manual dexterity with patient errors using current pMDIs, SMIs and/or DPIs.

COPD

COPD Foundation500 participantsStarted Dec 2023

Birmingham, Alabama, United States • Chicago, Illinois, United States • Burlington, Massachusetts, United States +6 more locations

RECRUITINGNA< 1 mile

Women's Heart Attack Research Program: Stress Ancillary Study

NCT02914483

The Women's HARP study is a multi-center study focusing on women with clinical presentation of myocardial infarction (MI). Women will complete stress questionnaires following presentation to the medical center with elevated cardiac enzymes and abnormal electrocardiograms (ECGs). 2 months following MI, participants will be screened for the Stress Ancillary Study and enrolled if an elevated level of perceived stress is reported. After completing baseline assessments, participants will be randomized to Enhanced Usual Care (EUC) or stress management for 8 weeks. Participants will be followed for 6 months.

Myocardial Infarction

NYU Langone Health200 participantsStarted Aug 2016

Los Angeles, California, United States • Gainesville, Florida, United States • Atlanta, Georgia, United States +11 more locations

Impairments That Affect Correct Inhaler Use in COPD

Women's Heart Attack Research Program: Stress Ancillary Study

Find Trials by Condition in Pittsburgh

Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC

PRV-3279-2a Trial in Systemic Lupus

Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD

Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout

Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.

Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness

Efficacy in iNPH Shunting (PENS) Trial

Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM

Adalimumab in JIA-associated Uveitis Stopping Trial

Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC

Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts

Trauma Informed Guilt Reduction Therapy

Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery

Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma